Tessera private stock trade

Tessera

Legal NameTessera Therapeutics, Inc.
HeadquartersCambridge, MA
SectorBioTech

Tessera Therapeutics is a biotechnology company pioneering Gene Writing™, a groundbreaking technology that enables precise and efficient genetic modifications for therapeutic purposes. The company specializes in developing innovative treatments for a wide range of diseases by harnessing the power of gene editing and synthetic biology. Tessera Therapeutics focuses on advancing gene therapies that can address complex genetic disorders with high precision and safety. Its research and development efforts integrate cutting-edge technologies to engineer therapeutic genetic circuits and optimize delivery methods, aiming to transform the landscape of genetic medicine. The company is committed to advancing healthcare through its innovative approach to genetic engineering and therapeutic development.

Learn more about Tessera IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Tessera, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Tessera, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.